Irofulven in Treating Patients With Stage IV Melanoma

Completed · Phase 2

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irofulven in treating patients who have stage IV melanoma.

Key facts

Study ID

NCT00005968

Run by

University of Colorado, Denver

Starts

1999-11-01

Expected to finish

2002-12-01

Last updated by the study team

2013-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• John Wayne Cancer Institute — Santa Monica, California, United States
• Veterans Affairs Medical Center - Denver — Denver, Colorado, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Lutheran General Hospital — Park Ridge, Illinois, United States
• Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.